Clinically proven, non-invasive, and easy for patients to use at home—Elitone and Elitone URGE fill the treatment gap for mild-to-moderate urinary incontinence.
Many women delay or avoid treatment due to the invasiveness or inconvenience of traditional options. Elitone offers:
We’ve interviewed hundreds of clinicians about the challenges they see in managing mild-moderate incontinence patients. Which do you relate to?
Low Patient Follow-Through on Conservative Treatments
…..
Limited Tools Between PT and Surgery
…..
Clinic Time Constraints
……
Patient Reluctance Toward Invasive Options
…..
Insurance and Reimbursement Friction
….
Elitone and Elitone URGE precisely deliver pelvic floor stimulation to effectively treat the most common types of incontinence.
Over 30,000 women have used Elitone and Elitone URGE to treat incontinence. Clinical studies that supported FDA-clearance reported:
Neuromuscular stimulation has been used to improve pelvic function for decades. Elitone builds on this history by delivering well proven waveforms through patented, easy-to-apply GelPads. Numerous clinical studies have demonstrated safety and efficacy including:
6-week study of SUI
…..
12 Week RCT for SUI
Toggle Content goes here
12 week study for UUI
Toggle Content goes here
Ultrasound Visualization
Toggle Content goes here
Comparison to Alternatives
Toggle Content goes here
Elitone is discreet, wearable, and doesn’t interrupt the patient’s day — increasing likelihood of adherence and positive outcomes.
Elitone underwent rigorous testing to obtain both Rx and OTC clearance, providing greater access for your patients. We also offer.
Patient Pay (most popular)
…..
HSA/FSA
…..
Traditional Medicare (Part B)
…..
Medicare Advantage, Medicaid, Private Payers
…..
Elitone complements your current care plans without adding burden to your schedule. Ideal for:
